Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SFTSV Gn‐Head mRNA vaccine confers efficient protection against lethal viral challenge
Do-Kyun Kim, Chih‐Jen Lai, In‐Ho Cha, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 11
Open Access | Times Cited: 14

Showing 14 citing articles:

Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 54
mRNA vaccines for infectious diseases — advances, challenges and opportunities
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 23
Current Progress of Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) Vaccine Development
Do-Kyun Kim, Chih‐Jen Lai, In‐Ho Cha, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 128-128
Open Access | Times Cited: 11
The Adaptive Immune Response against Bunyavirales
Reem Alatrash, Bobby Brooke Herrera
Viruses (2024) Vol. 16, Iss. 3, pp. 483-483
Open Access | Times Cited: 5
Identification of Licoflavone C as a cap-dependent endonuclease inhibitor against severe fever with thrombocytopenia syndrome virus
Xiao Gao, Xiaoxue He, Xuerui Zhu, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
The immunogenicity and protection efficacy evaluation of mRNA vaccine candidate for severe fever with thrombocytopenia syndrome in mice
Daeun Jeong, Jack Yoon, Baek Kim, et al.
PLoS neglected tropical diseases (2025) Vol. 19, Iss. 4, pp. e0012999-e0012999
Open Access
Current Advances in Vaccine Development for Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV)
Hyo‐Jin Ro, Nam‐Hyuk Cho
Zoonoses (2025) Vol. 5, Iss. 1
Open Access
A full-length glycoprotein mRNA vaccine confers complete protection against severe fever with thrombocytopenia syndrome virus, with broad-spectrum protective effects against bandaviruses
Jia Lu, Jun Liu, Yan Wu, et al.
Journal of Virology (2024) Vol. 98, Iss. 7
Open Access | Times Cited: 3
Recombinant ferritin-based nanoparticles as neoantigen carriers significantly inhibit tumor growth and metastasis
Wei Zheng, Shixiong Li, Zhongliang Shi, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
The Adaptive Immune Response against Bunyaviruses
Reem Alatrash, Bobby Brooke Herrera
(2024)
Open Access | Times Cited: 1
Recent research advances in the development of Dabie Banda virus vaccines
Chenyang Yu, Yuxiang Lin, Yixin Dai, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 8, pp. e0012411-e0012411
Open Access | Times Cited: 1
Molecular mechanism and structure-guided humanization of a broadly neutralizing antibody against SFTSV
Pinyi Yang, Xiaoli Wu, Hang Shang, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012550-e1012550
Open Access | Times Cited: 1
Safety, Immunogenicity, and Efficacy of a Recombinant Vesicular Stomatitis Virus Vectored Vaccine Against Severe Fever with Thrombocytopenia Syndrome Virus and Heartland Bandavirus
Philip Hicks, Tomaz B. Manzoni, Jonna B. Westover, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1403-1403
Open Access | Times Cited: 1
Lipid Nanoparticle (LNP) Delivery Vector-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
(2023)
Open Access | Times Cited: 1
Recombinant ferritin-based nanoparticles as neoantigen carriers significantly inhibit tumor growth and metastasis
Wei Zheng, Shixiong Li, Zhongliang Shi, et al.
Research Square (Research Square) (2024)
Open Access
Molecular insight into the neutralization mechanism of human-origin monoclonal antibody AH100 against Hantaan virus
Feiran Wang, Tiezhu Liu, Liying Liao, et al.
Journal of Virology (2024) Vol. 98, Iss. 8
Closed Access
Page 1

Scroll to top